The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing.

The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing.

Target repurposing utilizes knowledge of "druggable" targets obtained in one organism and exploits this information to pursue new potential drug targets in other organisms. Here we describe such studies to evaluate whether inhibitors targeting the kinase domain of the mammalian Target of R...

Full description

Bibliographic Details
Main Authors: Rosario Diaz-Gonzalez, F Matthew Kuhlmann, Cristina Galan-Rodriguez, Luciana Madeira da Silva, Manuel Saldivia, Caitlin E Karver, Ana Rodriguez, Stephen M Beverley, Miguel Navarro, Michael P Pollastri
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-08-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC3160303?pdf=render

Internet

http://europepmc.org/articles/PMC3160303?pdf=render

Similar Items